MBXHealthcareSmall-Cap

MBX Biosciences, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for MBX Biosciences, Inc. (MBX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are MBX insiders buying or selling?

MBX Biosciences, Inc. insiders reported 23 open-market buys ($153.7M) and 3 sells ($2.7M) across 26 Form 4 filings — a net buying position of $151.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 11, 2026)

Total Form 4 filings
26
SEC EDGAR
Insider filers
19
Insider buys (23)
$153.7M
Insider sells (3)
$2.7M

Insider sentiment

Net buying

Net insider flow of $151.0M in net buying.

Recent MBX insider transactions

DateInsiderRoleTypeSharesPriceValue
May 11, 2026Salomon AzoulayChief Medical OfficerSale70.0K$38.36$2.7M
May 8, 2026Salomon AzoulayChief Medical OfficerSale231$29.54$6.8K
May 8, 2026Hawryluk P. KentPresident & CEOSale607$29.54$17.9K
Mar 16, 2026Hawryluk P. KentPresident & CEOPurchase18.5K$28.41$525.7K
Oct 21, 2025Hawryluk P. KentPresident & CEOPurchase20.0K$13.64$272.8K
Oct 20, 2025Steven L. HoerterDirectorPurchase20.0K$13.25$265.0K
Sep 30, 2025Patrick J HeronDirector, 10% OwnerPurchase666.7K$18.00$12.0M
Apr 10, 2025Ora H. PescovitzDirectorPurchase7.7K$5.89$45.3K
Feb 19, 2025Carl L GordonDirector, 10% OwnerPurchase190.7K$10.60$2.0M
Feb 19, 2025ORBIMED ADVISORS LLCDirector, 10% OwnerPurchase190.7K$10.60$2.0M
Feb 5, 2025Hawryluk P. KentPresident & CEOPurchase50.0K$10.69$534.5K
Sep 18, 2024Edward T MathersDirector, 10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Forest Baskett10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Ali Behbahani10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Carmen Chang10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Anthony A. Florence Jr.10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Mohamad Makhzoumi10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Paul Edward Walker10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Rick Yang10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024Scott D Sandell10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024ORBIMED ADVISORS LLCDirector, 10% OwnerPurchase750.0K$16.00$12.0M
Sep 18, 2024New Enterprise Associates 17, L.P.10% OwnerPurchase500.0K$16.00$8.0M
Sep 18, 2024James N Topper10% OwnerPurchase625.0K$16.00$10.0M
Sep 18, 2024Patrick J HeronDirector, 10% OwnerPurchase625.0K$16.00$10.0M
Sep 18, 2024Tiba AynechiDirectorPurchase750.0K$16.00$12.0M

Showing the 25 most recent of 26 Form 4 filings for MBX Biosciences, Inc..

Most active MBX insiders

  • Hawryluk P. Kent4 filings
  • Carl L Gordon2 filings
  • ORBIMED ADVISORS LLC2 filings
  • Patrick J Heron2 filings
  • Salomon Azoulay2 filings

Ask anything about MBX insider activity

Use Trabud's AI agent to query MBX Biosciences, Inc.'s Form 4 history in plain English — "Show me MBX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MBX insider trading FAQ

Are MBX Biosciences, Inc. insiders buying or selling?

Across 26 SEC Form 4 filings, MBX Biosciences, Inc. (MBX) insiders reported 23 open-market purchases totaling $153.7M and 3 sales totaling $2.7M. That is a net buying position of $151.0M.

How many insiders trade MBX stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MBX Biosciences, Inc.. The most recent filing was accepted on May 11, 2026.

Where does Trabud get MBX insider trading data?

All MBX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content